BioMarin to Attend Upcoming Investor Conference

BioMarin to Attend Upcoming Investor Conference

- Bank of America Merrill Lynch Health Care Conference on May 15 in Las Vegas

PR Newswire

SAN RAFAEL, Calif., May 2, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. BMRN, today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the Bank of America Merrill Lynch Health Care Conference on May 15, 2018 at 10:40am PT/1:40pm ET in Las Vegas.  To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:







Investors

Media

Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/biomarin-to-attend-upcoming-investor-conference-300640380.html

SOURCE BioMarin Pharmaceutical Inc.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press ReleasesConference Call Announcementstrade shows
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!